0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Compounded Bioidentical Hormone Therapy Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-4A13663
Home | Market Reports | Health| Men s Health
Global Compounded Bioidentical Hormone Therapy Market Research Report 2023
BUY CHAPTERS

Global Compounded Bioidentical Hormone Therapy Market Research Report 2025

Code: QYRE-Auto-4A13663
Report
February 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Compounded Bioidentical Hormone Therapy Market Size

The global market for Compounded Bioidentical Hormone Therapy was valued at US$ 1496 million in the year 2024 and is projected to reach a revised size of US$ 2179 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Compounded Bioidentical Hormone Therapy Market

Compounded Bioidentical Hormone Therapy Market

Bioidentical hormones are artificial hormones that are chemically similar to those naturallyproduced by the human body. Because they are chemically similar to the hormones produced by the body, bioidentical hormones act as the body"s own hormones with very few side effects.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Compounded Bioidentical Hormone Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounded Bioidentical Hormone Therapy.
The Compounded Bioidentical Hormone Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Compounded Bioidentical Hormone Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Compounded Bioidentical Hormone Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Compounded Bioidentical Hormone Therapy Market Report

Report Metric Details
Report Name Compounded Bioidentical Hormone Therapy Market
Accounted market size in year US$ 1496 million
Forecasted market size in 2031 US$ 2179 million
CAGR 5.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals, Novartis AG, Pfizer, TherapeuticsMD, Bayer AG, Novo Nordisk
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Compounded Bioidentical Hormone Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Compounded Bioidentical Hormone Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Compounded Bioidentical Hormone Therapy Market growing?

Ans: The Compounded Bioidentical Hormone Therapy Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Compounded Bioidentical Hormone Therapy Market size in 2031?

Ans: The Compounded Bioidentical Hormone Therapy Market size in 2031 will be US$ 2179 million.

Who are the main players in the Compounded Bioidentical Hormone Therapy Market report?

Ans: The main players in the Compounded Bioidentical Hormone Therapy Market are SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Bio station, Noven Pharmaceuticals, Novartis AG, Pfizer, TherapeuticsMD, Bayer AG, Novo Nordisk

What are the Application segmentation covered in the Compounded Bioidentical Hormone Therapy Market report?

Ans: The Applications covered in the Compounded Bioidentical Hormone Therapy Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

What are the Type segmentation covered in the Compounded Bioidentical Hormone Therapy Market report?

Ans: The Types covered in the Compounded Bioidentical Hormone Therapy Market report are Oestrogen, Progesterone, Testosterone

Recommended Reports

Hormone & Endocrine Therapy

Pharmaceutical Innovations

Medical Devices & Therapies

1 Compounded Bioidentical Hormone Therapy Market Overview
1.1 Product Definition
1.2 Compounded Bioidentical Hormone Therapy by Type
1.2.1 Global Compounded Bioidentical Hormone Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oestrogen
1.2.3 Progesterone
1.2.4 Testosterone
1.3 Compounded Bioidentical Hormone Therapy by Application
1.3.1 Global Compounded Bioidentical Hormone Therapy Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Compounded Bioidentical Hormone Therapy Market Size Estimates and Forecasts
1.4.1 Global Compounded Bioidentical Hormone Therapy Revenue 2020-2031
1.4.2 Global Compounded Bioidentical Hormone Therapy Sales 2020-2031
1.4.3 Global Compounded Bioidentical Hormone Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Compounded Bioidentical Hormone Therapy Market Competition by Manufacturers
2.1 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Compounded Bioidentical Hormone Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Compounded Bioidentical Hormone Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Compounded Bioidentical Hormone Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Compounded Bioidentical Hormone Therapy, Product Type & Application
2.7 Global Key Manufacturers of Compounded Bioidentical Hormone Therapy, Date of Enter into This Industry
2.8 Global Compounded Bioidentical Hormone Therapy Market Competitive Situation and Trends
2.8.1 Global Compounded Bioidentical Hormone Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Compounded Bioidentical Hormone Therapy Players Market Share by Revenue
2.8.3 Global Compounded Bioidentical Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Compounded Bioidentical Hormone Therapy Market Scenario by Region
3.1 Global Compounded Bioidentical Hormone Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Compounded Bioidentical Hormone Therapy Sales by Region: 2020-2031
3.2.1 Global Compounded Bioidentical Hormone Therapy Sales by Region: 2020-2025
3.2.2 Global Compounded Bioidentical Hormone Therapy Sales by Region: 2026-2031
3.3 Global Compounded Bioidentical Hormone Therapy Revenue by Region: 2020-2031
3.3.1 Global Compounded Bioidentical Hormone Therapy Revenue by Region: 2020-2025
3.3.2 Global Compounded Bioidentical Hormone Therapy Revenue by Region: 2026-2031
3.4 North America Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.4.1 North America Compounded Bioidentical Hormone Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Compounded Bioidentical Hormone Therapy Sales by Country (2020-2031)
3.4.3 North America Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.5.1 Europe Compounded Bioidentical Hormone Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Compounded Bioidentical Hormone Therapy Sales by Country (2020-2031)
3.5.3 Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Compounded Bioidentical Hormone Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Compounded Bioidentical Hormone Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.7.1 Latin America Compounded Bioidentical Hormone Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Compounded Bioidentical Hormone Therapy Sales by Country (2020-2031)
3.7.3 Latin America Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Compounded Bioidentical Hormone Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Compounded Bioidentical Hormone Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Compounded Bioidentical Hormone Therapy Sales by Type (2020-2031)
4.1.1 Global Compounded Bioidentical Hormone Therapy Sales by Type (2020-2025)
4.1.2 Global Compounded Bioidentical Hormone Therapy Sales by Type (2026-2031)
4.1.3 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2020-2031)
4.2 Global Compounded Bioidentical Hormone Therapy Revenue by Type (2020-2031)
4.2.1 Global Compounded Bioidentical Hormone Therapy Revenue by Type (2020-2025)
4.2.2 Global Compounded Bioidentical Hormone Therapy Revenue by Type (2026-2031)
4.2.3 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Compounded Bioidentical Hormone Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Compounded Bioidentical Hormone Therapy Sales by Application (2020-2031)
5.1.1 Global Compounded Bioidentical Hormone Therapy Sales by Application (2020-2025)
5.1.2 Global Compounded Bioidentical Hormone Therapy Sales by Application (2026-2031)
5.1.3 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2020-2031)
5.2 Global Compounded Bioidentical Hormone Therapy Revenue by Application (2020-2031)
5.2.1 Global Compounded Bioidentical Hormone Therapy Revenue by Application (2020-2025)
5.2.2 Global Compounded Bioidentical Hormone Therapy Revenue by Application (2026-2031)
5.2.3 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Compounded Bioidentical Hormone Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 SottoPelle
6.1.1 SottoPelle Company Information
6.1.2 SottoPelle Description and Business Overview
6.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 SottoPelle Compounded Bioidentical Hormone Therapy Product Portfolio
6.1.5 SottoPelle Recent Developments/Updates
6.2 BioTE Medical
6.2.1 BioTE Medical Company Information
6.2.2 BioTE Medical Description and Business Overview
6.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioTE Medical Compounded Bioidentical Hormone Therapy Product Portfolio
6.2.5 BioTE Medical Recent Developments/Updates
6.3 Advantage Pharmaceuticals
6.3.1 Advantage Pharmaceuticals Company Information
6.3.2 Advantage Pharmaceuticals Description and Business Overview
6.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Portfolio
6.3.5 Advantage Pharmaceuticals Recent Developments/Updates
6.4 Full Life Wellness Center
6.4.1 Full Life Wellness Center Company Information
6.4.2 Full Life Wellness Center Description and Business Overview
6.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Portfolio
6.4.5 Full Life Wellness Center Recent Developments/Updates
6.5 Neuva Aesthetics
6.5.1 Neuva Aesthetics Company Information
6.5.2 Neuva Aesthetics Description and Business Overview
6.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Portfolio
6.5.5 Neuva Aesthetics Recent Developments/Updates
6.6 Defy Medical
6.6.1 Defy Medical Company Information
6.6.2 Defy Medical Description and Business Overview
6.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Defy Medical Compounded Bioidentical Hormone Therapy Product Portfolio
6.6.5 Defy Medical Recent Developments/Updates
6.7 Bio station
6.7.1 Bio station Company Information
6.7.2 Bio station Description and Business Overview
6.7.3 Bio station Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio station Compounded Bioidentical Hormone Therapy Product Portfolio
6.7.5 Bio station Recent Developments/Updates
6.8 Noven Pharmaceuticals
6.8.1 Noven Pharmaceuticals Company Information
6.8.2 Noven Pharmaceuticals Description and Business Overview
6.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Portfolio
6.8.5 Noven Pharmaceuticals Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Company Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Novartis AG Compounded Bioidentical Hormone Therapy Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Company Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfizer Compounded Bioidentical Hormone Therapy Product Portfolio
6.10.5 Pfizer Recent Developments/Updates
6.11 TherapeuticsMD
6.11.1 TherapeuticsMD Company Information
6.11.2 TherapeuticsMD Description and Business Overview
6.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.11.4 TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Portfolio
6.11.5 TherapeuticsMD Recent Developments/Updates
6.12 Bayer AG
6.12.1 Bayer AG Company Information
6.12.2 Bayer AG Description and Business Overview
6.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bayer AG Compounded Bioidentical Hormone Therapy Product Portfolio
6.12.5 Bayer AG Recent Developments/Updates
6.13 Novo Nordisk
6.13.1 Novo Nordisk Company Information
6.13.2 Novo Nordisk Description and Business Overview
6.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Novo Nordisk Compounded Bioidentical Hormone Therapy Product Portfolio
6.13.5 Novo Nordisk Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Compounded Bioidentical Hormone Therapy Industry Chain Analysis
7.2 Compounded Bioidentical Hormone Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Compounded Bioidentical Hormone Therapy Production Mode & Process Analysis
7.4 Compounded Bioidentical Hormone Therapy Sales and Marketing
7.4.1 Compounded Bioidentical Hormone Therapy Sales Channels
7.4.2 Compounded Bioidentical Hormone Therapy Distributors
7.5 Compounded Bioidentical Hormone Therapy Customer Analysis
8 Compounded Bioidentical Hormone Therapy Market Dynamics
8.1 Compounded Bioidentical Hormone Therapy Industry Trends
8.2 Compounded Bioidentical Hormone Therapy Market Drivers
8.3 Compounded Bioidentical Hormone Therapy Market Challenges
8.4 Compounded Bioidentical Hormone Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Compounded Bioidentical Hormone Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Compounded Bioidentical Hormone Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Compounded Bioidentical Hormone Therapy Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Compounded Bioidentical Hormone Therapy Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Compounded Bioidentical Hormone Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Compounded Bioidentical Hormone Therapy Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Compounded Bioidentical Hormone Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Compounded Bioidentical Hormone Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Compounded Bioidentical Hormone Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Compounded Bioidentical Hormone Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of Compounded Bioidentical Hormone Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Compounded Bioidentical Hormone Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounded Bioidentical Hormone Therapy as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Compounded Bioidentical Hormone Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Compounded Bioidentical Hormone Therapy Sales by Region (2020-2025) & (K Units)
 Table 18. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2020-2025)
 Table 19. Global Compounded Bioidentical Hormone Therapy Sales by Region (2026-2031) & (K Units)
 Table 20. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2026-2031)
 Table 21. Global Compounded Bioidentical Hormone Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Region (2020-2025)
 Table 23. Global Compounded Bioidentical Hormone Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Region (2026-2031)
 Table 25. North America Compounded Bioidentical Hormone Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Compounded Bioidentical Hormone Therapy Sales by Country (2020-2025) & (K Units)
 Table 27. North America Compounded Bioidentical Hormone Therapy Sales by Country (2026-2031) & (K Units)
 Table 28. North America Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Compounded Bioidentical Hormone Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Compounded Bioidentical Hormone Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Compounded Bioidentical Hormone Therapy Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Compounded Bioidentical Hormone Therapy Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Compounded Bioidentical Hormone Therapy Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Compounded Bioidentical Hormone Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Compounded Bioidentical Hormone Therapy Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Compounded Bioidentical Hormone Therapy Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Compounded Bioidentical Hormone Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Compounded Bioidentical Hormone Therapy Sales (K Units) by Type (2020-2025)
 Table 51. Global Compounded Bioidentical Hormone Therapy Sales (K Units) by Type (2026-2031)
 Table 52. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2020-2025)
 Table 53. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2026-2031)
 Table 54. Global Compounded Bioidentical Hormone Therapy Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Compounded Bioidentical Hormone Therapy Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2020-2025)
 Table 57. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2026-2031)
 Table 58. Global Compounded Bioidentical Hormone Therapy Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Compounded Bioidentical Hormone Therapy Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Compounded Bioidentical Hormone Therapy Sales (K Units) by Application (2020-2025)
 Table 61. Global Compounded Bioidentical Hormone Therapy Sales (K Units) by Application (2026-2031)
 Table 62. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2020-2025)
 Table 63. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2026-2031)
 Table 64. Global Compounded Bioidentical Hormone Therapy Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Compounded Bioidentical Hormone Therapy Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2020-2025)
 Table 67. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2026-2031)
 Table 68. Global Compounded Bioidentical Hormone Therapy Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Compounded Bioidentical Hormone Therapy Price (US$/Unit) by Application (2026-2031)
 Table 70. SottoPelle Company Information
 Table 71. SottoPelle Description and Business Overview
 Table 72. SottoPelle Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. SottoPelle Compounded Bioidentical Hormone Therapy Product
 Table 74. SottoPelle Recent Developments/Updates
 Table 75. BioTE Medical Company Information
 Table 76. BioTE Medical Description and Business Overview
 Table 77. BioTE Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BioTE Medical Compounded Bioidentical Hormone Therapy Product
 Table 79. BioTE Medical Recent Developments/Updates
 Table 80. Advantage Pharmaceuticals Company Information
 Table 81. Advantage Pharmaceuticals Description and Business Overview
 Table 82. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product
 Table 84. Advantage Pharmaceuticals Recent Developments/Updates
 Table 85. Full Life Wellness Center Company Information
 Table 86. Full Life Wellness Center Description and Business Overview
 Table 87. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product
 Table 89. Full Life Wellness Center Recent Developments/Updates
 Table 90. Neuva Aesthetics Company Information
 Table 91. Neuva Aesthetics Description and Business Overview
 Table 92. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product
 Table 94. Neuva Aesthetics Recent Developments/Updates
 Table 95. Defy Medical Company Information
 Table 96. Defy Medical Description and Business Overview
 Table 97. Defy Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Defy Medical Compounded Bioidentical Hormone Therapy Product
 Table 99. Defy Medical Recent Developments/Updates
 Table 100. Bio station Company Information
 Table 101. Bio station Description and Business Overview
 Table 102. Bio station Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bio station Compounded Bioidentical Hormone Therapy Product
 Table 104. Bio station Recent Developments/Updates
 Table 105. Noven Pharmaceuticals Company Information
 Table 106. Noven Pharmaceuticals Description and Business Overview
 Table 107. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product
 Table 109. Noven Pharmaceuticals Recent Developments/Updates
 Table 110. Novartis AG Company Information
 Table 111. Novartis AG Description and Business Overview
 Table 112. Novartis AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Novartis AG Compounded Bioidentical Hormone Therapy Product
 Table 114. Novartis AG Recent Developments/Updates
 Table 115. Pfizer Company Information
 Table 116. Pfizer Description and Business Overview
 Table 117. Pfizer Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Pfizer Compounded Bioidentical Hormone Therapy Product
 Table 119. Pfizer Recent Developments/Updates
 Table 120. TherapeuticsMD Company Information
 Table 121. TherapeuticsMD Description and Business Overview
 Table 122. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. TherapeuticsMD Compounded Bioidentical Hormone Therapy Product
 Table 124. TherapeuticsMD Recent Developments/Updates
 Table 125. Bayer AG Company Information
 Table 126. Bayer AG Description and Business Overview
 Table 127. Bayer AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Bayer AG Compounded Bioidentical Hormone Therapy Product
 Table 129. Bayer AG Recent Developments/Updates
 Table 130. Novo Nordisk Company Information
 Table 131. Novo Nordisk Description and Business Overview
 Table 132. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Novo Nordisk Compounded Bioidentical Hormone Therapy Product
 Table 134. Novo Nordisk Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Compounded Bioidentical Hormone Therapy Distributors List
 Table 138. Compounded Bioidentical Hormone Therapy Customers List
 Table 139. Compounded Bioidentical Hormone Therapy Market Trends
 Table 140. Compounded Bioidentical Hormone Therapy Market Drivers
 Table 141. Compounded Bioidentical Hormone Therapy Market Challenges
 Table 142. Compounded Bioidentical Hormone Therapy Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Compounded Bioidentical Hormone Therapy
 Figure 2. Global Compounded Bioidentical Hormone Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Compounded Bioidentical Hormone Therapy Market Share by Type: 2024 & 2031
 Figure 4. Oestrogen Product Picture
 Figure 5. Progesterone Product Picture
 Figure 6. Testosterone Product Picture
 Figure 7. Global Compounded Bioidentical Hormone Therapy Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Compounded Bioidentical Hormone Therapy Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Online Pharmacies
 Figure 12. Others
 Figure 13. Global Compounded Bioidentical Hormone Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Compounded Bioidentical Hormone Therapy Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Compounded Bioidentical Hormone Therapy Sales (2020-2031) & (K Units)
 Figure 16. Global Compounded Bioidentical Hormone Therapy Average Price (US$/Unit) & (2020-2031)
 Figure 17. Compounded Bioidentical Hormone Therapy Report Years Considered
 Figure 18. Compounded Bioidentical Hormone Therapy Sales Share by Manufacturers in 2024
 Figure 19. Global Compounded Bioidentical Hormone Therapy Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Compounded Bioidentical Hormone Therapy Players: Market Share by Revenue in Compounded Bioidentical Hormone Therapy in 2024
 Figure 21. Compounded Bioidentical Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Compounded Bioidentical Hormone Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2020-2031)
 Figure 24. North America Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2020-2031)
 Figure 28. Europe Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Compounded Bioidentical Hormone Therapy Revenue Market Share by Region (2020-2031)
 Figure 36. China Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Compounded Bioidentical Hormone Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Compounded Bioidentical Hormone Therapy by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Compounded Bioidentical Hormone Therapy by Type (2020-2031)
 Figure 58. Global Compounded Bioidentical Hormone Therapy Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Compounded Bioidentical Hormone Therapy by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Compounded Bioidentical Hormone Therapy by Application (2020-2031)
 Figure 61. Global Compounded Bioidentical Hormone Therapy Price (US$/Unit) by Application (2020-2031)
 Figure 62. Compounded Bioidentical Hormone Therapy Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD